Search

Your search keyword '"Blakaj D"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Blakaj D" Remove constraint Author: "Blakaj D"
138 results on '"Blakaj D"'

Search Results

5. Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016

7. Pulse parameter optimizer: an efficient tool for achieving prescribed dose and dose rate with electron FLASH platforms.

9. 888P Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors

12. 948P Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

13. Treatment outcomes of head and neck cancer patients 70 years and older receiving different chemo-radiation combinations

14. A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

15. A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report

17. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma

18. NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

19. Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

26. Human Papillomavirus Status and Long-Term Outcomes for Stage III-IV Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx Treated With a Multimodal Intensification Regimen

30. Development of a Head and Neck Multidisciplinary Patient Education Binder

31. Survival Is Independent of Radiation Therapy Treatment Center Experience After Surgical Therapy

36. OC-0493: Head and neck cancer HPV16 variant analysis, HPV E2 variations and E2 protein disruption as radiation sensitivity biomarker

37. Papillomavirus E2 Protein as a Biomarker for Radiation Sensitivity in HPV Associated Head and Neck Squamous Cell Carcinoma

38. The Impact of Smoking on Laryngeal Preservation in Locally Advanced Laryngeal Cancer Treated With Definitive Chemoradiation Therapy

39. Durable Cosmetic Control With Radiation Therapy for HIV-Associated Parotid Benign Lymphoepithelial Cysts

40. The Impact of Different Radiation Therapy Techniques on Oncologic and Functional Outcomes of Locally Advanced Laryngeal Cancer

41. Higher Energy Megavoltage Photon and Split Beam Technique Minimize the Testicular Dose During Radiation Prophylaxis of Heterotopic Ossification

49. Dosimetric Analysis of Salvage SBRT Reirradiation after Initial Spine SBRT; Single Institution Experience.

50. HPV-Seq is Prognostic in p16-Positive Oropharyngeal Cancer (OPC): Independent Validation on a Large Prospective Cohort and a Secondary Analysis of NRG-HN002.

Catalog

Books, media, physical & digital resources